You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
A Phase I open randomized non-comparative parallel group study of potential cytochrome P450 3A induction after repeat twice daily oral dosing with 100 and 500 mg AZD1981 tablets for 14 days to healthy male volunteers with single oral doses of midazolam 7.5 mg
- Disease
- chronic obstructive pulmonary disease, asthma
- Drug Name
- AZD1981
- Generic Name
- AZD1981
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Aug 2, 2008
- Study Name
- D9831C00005
- Study Id
- D9831C00005
- ClinicalTrials.gov ID
- NCT00698282
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
